Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange Detected- Added a government funding/operating status notice and a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the resource: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (v3.1.0).SummaryDifference2%

- Check26 days agoChange DetectedUpdated contact details and new software revision (v3.1.0) replace an old disease term and older revision (v3.0.2).SummaryDifference0.2%

- Check40 days agoChange DetectedThe page version updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' navigation element was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific drug information for Pembrolizumab and detailed resources related to various gastrointestinal diseases, while also removing some location-related terms and previous drug classifications.SummaryDifference3%

- Check62 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.1%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.